These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 31029657)
1. Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate. Elnaggar YSR; Omran S; Hazzah HA; Abdallah OY Int J Pharm; 2019 Jun; 564():410-425. PubMed ID: 31029657 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization. Khalil RM; Abdelbary A; Kocova El-Arini S; Basha M; El-Hashemy HA J Liposome Res; 2019 Jun; 29(2):171-182. PubMed ID: 30221568 [TBL] [Abstract][Full Text] [Related]
3. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Al-Mahallawi AM; Abdelbary AA; Aburahma MH Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122 [TBL] [Abstract][Full Text] [Related]
4. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability. He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310 [TBL] [Abstract][Full Text] [Related]
5. Readily restoring freeze-dried probilosomes as potential nanocarriers for enhancing oral delivery of cyclosporine A. Guan P; Lu Y; Qi J; Wu W Colloids Surf B Biointerfaces; 2016 Aug; 144():143-151. PubMed ID: 27085046 [TBL] [Abstract][Full Text] [Related]
6. Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats. Ahad A; Raish M; Ahmad A; Al-Jenoobi FI; Al-Mohizea AM Eur J Pharm Sci; 2018 Jan; 111():409-417. PubMed ID: 29030177 [TBL] [Abstract][Full Text] [Related]
7. Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). Shukla A; Khatri K; Gupta PN; Goyal AK; Mehta A; Vyas SP J Pharm Pharm Sci; 2008; 11(1):59-66. PubMed ID: 18445364 [TBL] [Abstract][Full Text] [Related]
8. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598 [TBL] [Abstract][Full Text] [Related]
9. Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug. Arafat M; Kirchhoefer C; Mikov M; Sarfraz M; Löbenberg R J Pharm Pharm Sci; 2017; 20(0):305-318. PubMed ID: 28885915 [TBL] [Abstract][Full Text] [Related]
10. Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and El-Nabarawi MA; Shamma RN; Farouk F; Nasralla SM J Liposome Res; 2020 Mar; 30(1):1-11. PubMed ID: 31010357 [TBL] [Abstract][Full Text] [Related]
11. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles. Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120 [TBL] [Abstract][Full Text] [Related]
12. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose. Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880 [TBL] [Abstract][Full Text] [Related]
13. Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies. Santhosh S; Mukherjee D; Anbu J; Murahari M; Teja BV J Microencapsul; 2019 Jun; 36(4):338-355. PubMed ID: 31190594 [TBL] [Abstract][Full Text] [Related]
14. Permeation enhancers loaded bilosomes for improved intestinal absorption and cytotoxic activity of doxorubicin. Sultan AA; Saad GA; El Maghraby GM Int J Pharm; 2023 Jan; 630():122427. PubMed ID: 36435504 [TBL] [Abstract][Full Text] [Related]
15. Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Singh P; Prabakaran D; Jain S; Mishra V; Jaganathan KS; Vyas SP Int J Pharm; 2004 Jul; 278(2):379-90. PubMed ID: 15196642 [TBL] [Abstract][Full Text] [Related]
16. Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides. Ahmad J; Singhal M; Amin S; Rizwanullah M; Akhter S; Kamal MA; Haider N; Midoux P; Pichon C Curr Pharm Des; 2017; 23(11):1575-1588. PubMed ID: 28120725 [TBL] [Abstract][Full Text] [Related]
17. Bilosomes: A Novel Approach to Meet the Challenges in Oral Immunization. Chauhan MK; Sahoo PK; Rawat AS; Singh A; Bamrara A; Sharma D Recent Pat Drug Deliv Formul; 2015; 9(3):201-12. PubMed ID: 26072957 [TBL] [Abstract][Full Text] [Related]
18. Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes. Mohsen AM; Asfour MH; Salama AAA Drug Dev Ind Pharm; 2017 Dec; 43(12):2043-2054. PubMed ID: 28756693 [TBL] [Abstract][Full Text] [Related]
19. Novel Vesicular Bilosomal Delivery Systems for Dermal/Transdermal Applications. Suvarna V; Mallya R; Deshmukh K; Sawant B; Khan TA; Omri A Curr Drug Deliv; 2024; 21(7):961-977. PubMed ID: 37424346 [TBL] [Abstract][Full Text] [Related]
20. Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines. Aburahma MH Drug Deliv; 2016 Jul; 23(6):1847-67. PubMed ID: 25390191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]